Amy Ellis

1.2k total citations
38 papers, 760 citations indexed

About

Amy Ellis is a scholar working on Molecular Biology, Immunology and Virology. According to data from OpenAlex, Amy Ellis has authored 38 papers receiving a total of 760 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 15 papers in Immunology and 13 papers in Virology. Recurrent topics in Amy Ellis's work include HIV Research and Treatment (13 papers), Immune Cell Function and Interaction (13 papers) and Cancer therapeutics and mechanisms (11 papers). Amy Ellis is often cited by papers focused on HIV Research and Treatment (13 papers), Immune Cell Function and Interaction (13 papers) and Cancer therapeutics and mechanisms (11 papers). Amy Ellis collaborates with scholars based in United States, Australia and India. Amy Ellis's co-authors include Janet E. Mertz, Leonard A. Zwelling, Michael R. Hoane, William Plunkett, Lorraine A. Cazenave, Charles Koller, Miloslav Beran, Susan O’Brien, HM Kantarjian and MJ Keating and has published in prestigious journals such as Blood, The Journal of Immunology and Cancer.

In The Last Decade

Amy Ellis

36 papers receiving 743 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Amy Ellis United States 14 365 291 175 162 106 38 760
Zhiwen He China 11 241 0.7× 91 0.3× 134 0.8× 72 0.4× 143 1.3× 21 544
Lakshmanan Annamalai United States 17 231 0.6× 257 0.9× 285 1.6× 62 0.4× 58 0.5× 26 797
Pravin Patel United States 20 154 0.4× 205 0.7× 205 1.2× 294 1.8× 77 0.7× 40 886
Kathryn T. Iacono United States 11 368 1.0× 131 0.5× 537 3.1× 104 0.6× 149 1.4× 17 1.0k
Karen Chiang United States 15 468 1.3× 157 0.5× 118 0.7× 59 0.4× 84 0.8× 19 1.0k
Marco Craveiro United States 10 261 0.7× 150 0.5× 500 2.9× 79 0.5× 41 0.4× 15 830
Cédric Mongellaz France 9 161 0.4× 77 0.3× 293 1.7× 70 0.4× 54 0.5× 11 659
Anita Parmigiani United States 14 432 1.2× 68 0.2× 350 2.0× 260 1.6× 110 1.0× 18 972
Melanie R. Shakespear Australia 7 794 2.2× 153 0.5× 362 2.1× 85 0.5× 36 0.3× 7 1.0k
Karen Nahmod United States 14 221 0.6× 76 0.3× 287 1.6× 49 0.3× 64 0.6× 28 695

Countries citing papers authored by Amy Ellis

Since Specialization
Citations

This map shows the geographic impact of Amy Ellis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amy Ellis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amy Ellis more than expected).

Fields of papers citing papers by Amy Ellis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amy Ellis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amy Ellis. The network helps show where Amy Ellis may publish in the future.

Co-authorship network of co-authors of Amy Ellis

This figure shows the co-authorship network connecting the top 25 collaborators of Amy Ellis. A scholar is included among the top collaborators of Amy Ellis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amy Ellis. Amy Ellis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Petty, Stephanie & Amy Ellis. (2024). The meaning of autistic movements. Autism. 28(12). 3015–3020. 5 indexed citations
2.
Moriarty, Ryan V., Alexis J. Balgeman, Amy Ellis, et al.. (2023). CD8+ cells and small viral reservoirs facilitate post-ART control of SIV replication in M3+ Mauritian cynomolgus macaques initiated on ART two weeks post-infection. PLoS Pathogens. 19(9). e1011676–e1011676. 3 indexed citations
3.
Ellis, Amy, Ryan V. Moriarty, Alexis J. Balgeman, et al.. (2023). Host Immunity to Mycobacterium tuberculosis Infection Is Similar in Simian Immunodeficiency Virus (SIV)-Infected, Antiretroviral Therapy-Treated and SIV-Naïve Juvenile Macaques. Infection and Immunity. 91(5). e0055822–e0055822. 3 indexed citations
4.
Ellis, Amy, et al.. (2021). Mathematical modeling of N-803 treatment in SIV-infected non-human primates. PLoS Computational Biology. 17(7). e1009204–e1009204. 5 indexed citations
5.
6.
Ellis, Amy, Alexis J. Balgeman, Cassaundra L. Ameel, et al.. (2020). MAIT cells are functionally impaired in a Mauritian cynomolgus macaque model of SIV and Mtb co-infection. PLoS Pathogens. 16(5). e1008585–e1008585. 23 indexed citations
7.
Sutton, Matthew S., Amy Ellis, Alexis J. Balgeman, et al.. (2019). CD8β Depletion Does Not Prevent Control of Viral Replication or Protection from Challenge in Macaques Chronically Infected with a Live Attenuated Simian Immunodeficiency Virus. Journal of Virology. 93(15). 7 indexed citations
8.
Ameel, Cassaundra L., Amy Ellis, Alexis J. Balgeman, et al.. (2018). Preexisting Simian Immunodeficiency Virus Infection Increases Susceptibility to Tuberculosis in Mauritian Cynomolgus Macaques. Infection and Immunity. 86(12). 17 indexed citations
9.
Sutton, Matthew S., Amy Ellis, Ryan V. Moriarty, et al.. (2018). Acute-Phase CD4 + T Cell Responses Targeting Invariant Viral Regions Are Associated with Control of Live Attenuated Simian Immunodeficiency Virus. Journal of Virology. 92(21). 8 indexed citations
10.
Ellis, Amy, et al.. (2018). Characterization of major histocompatibility complex-related molecule 1 sequence variants in non-human primates. Immunogenetics. 71(2). 109–121. 6 indexed citations
11.
Carney, Edward W., Amy Ellis, Rochelle W. Tyl, et al.. (2011). Critical evaluation of current developmental toxicity testing strategies: a case of babies and their bathwater. Birth Defects Research Part B Developmental and Reproductive Toxicology. 92(5). 395–403. 21 indexed citations
12.
Makris, Susan L., James H. Kim, Amy Ellis, et al.. (2011). Current and future needs for developmental toxicity testing. Birth Defects Research Part B Developmental and Reproductive Toxicology. 92(5). 384–394. 16 indexed citations
13.
Hoane, Michael R., et al.. (2006). The effects of nicotinamide on apoptosis and blood–brain barrier breakdown following traumatic brain injury. Brain Research. 1125(1). 185–193. 74 indexed citations
14.
O’Brien, Susan, Hagop Kantarjian, Amy Ellis, et al.. (1995). Topotecan in chronic lymphocytic leukemia. Cancer. 75(5). 1104–1108. 14 indexed citations
15.
Ellis, Amy, Billie Nowak, William Plunkett, & Leonard A. Zwelling. (1994). Quantification of topoisomerase-DNA complexes in leukemia cells from patients undergoing therapy with a topoisomerase-directed agent. Cancer Chemotherapy and Pharmacology. 34(3). 249–256. 10 indexed citations
16.
Ellis, Amy, Elizabeth Altschuler, Elise S. Bales, et al.. (1994). Phorbol regulation of topoisomerases I and II in human leukemia cells. Biochemical Pharmacology. 47(2). 387–396. 4 indexed citations
17.
Ellis, Amy & Leonard A. Zwelling. (1994). Time course of phorbol-12-myristate-13-acetate (PMA)-induced down-regulation of topoisomerase II in human leukemia cells. Biochemical Pharmacology. 48(9). 1842–1845. 5 indexed citations
18.
Kantarjian, HM, Miloslav Beran, Amy Ellis, et al.. (1993). Phase I study of Topotecan, a new topoisomerase I inhibitor, in patients with refractory or relapsed acute leukemia. Blood. 81(5). 1146–1151. 81 indexed citations
19.
Ellis, Amy, Roderick T. Bunch, Joyce K. Randolph, et al.. (1992). Components of intrinsic drug resistance in the rat hepatoma. Biochemical Pharmacology. 43(2). 331–342. 8 indexed citations
20.
Ellis, Amy, et al.. (1989). Enhanced sensitivity of the rat hepatoma cell to the daunorubicin analogue 4-demethoxydaunorubicin associated with induction of DNA damage.. PubMed. 49(17). 4846–51. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Zhiwen He Breakdown of academic impact, for papers by Lakshmanan Annamalai Breakdown of academic impact, for papers by Pravin Patel Breakdown of academic impact, for papers by Kathryn T. Iacono Breakdown of academic impact, for papers by Karen Chiang Breakdown of academic impact, for papers by Marco Craveiro Breakdown of academic impact, for papers by Cédric Mongellaz Breakdown of academic impact, for papers by Anita Parmigiani Breakdown of academic impact, for papers by Melanie R. Shakespear Breakdown of academic impact, for papers by Karen Nahmod
Rankless by CCL
2026